PL3829551T3 - Krystaliczna sól malonianu epinefryny - Google Patents

Krystaliczna sól malonianu epinefryny

Info

Publication number
PL3829551T3
PL3829551T3 PL19845343.3T PL19845343T PL3829551T3 PL 3829551 T3 PL3829551 T3 PL 3829551T3 PL 19845343 T PL19845343 T PL 19845343T PL 3829551 T3 PL3829551 T3 PL 3829551T3
Authority
PL
Poland
Prior art keywords
malonate salt
epinephrine malonate
crystalline
crystalline epinephrine
salt
Prior art date
Application number
PL19845343.3T
Other languages
English (en)
Inventor
Jean-Pierre Sommadossi
Adel Moussa
Original Assignee
Biothea Pharma, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biothea Pharma, Inc. filed Critical Biothea Pharma, Inc.
Publication of PL3829551T3 publication Critical patent/PL3829551T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/08—Malonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
PL19845343.3T 2018-07-30 2019-07-29 Krystaliczna sól malonianu epinefryny PL3829551T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862711936P 2018-07-30 2018-07-30
US201862731442P 2018-09-14 2018-09-14
PCT/US2019/043856 WO2020028215A1 (en) 2018-07-30 2019-07-29 Crystalline epinephrine malonate salt

Publications (1)

Publication Number Publication Date
PL3829551T3 true PL3829551T3 (pl) 2024-04-02

Family

ID=69179001

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19845343.3T PL3829551T3 (pl) 2018-07-30 2019-07-29 Krystaliczna sól malonianu epinefryny

Country Status (20)

Country Link
US (4) US10995059B2 (pl)
EP (1) EP3829551B1 (pl)
JP (1) JP7561118B2 (pl)
KR (1) KR102847418B1 (pl)
CN (1) CN112739334B (pl)
AU (1) AU2019313324B2 (pl)
BR (1) BR112021001525A2 (pl)
CA (1) CA3123928C (pl)
ES (1) ES2973347T3 (pl)
HR (1) HRP20240162T1 (pl)
HU (1) HUE065984T2 (pl)
IL (1) IL280448B2 (pl)
MX (1) MX2021001249A (pl)
PL (1) PL3829551T3 (pl)
RS (1) RS65138B1 (pl)
SG (1) SG11202100749UA (pl)
SM (1) SMT202400056T1 (pl)
TW (1) TWI819045B (pl)
WO (1) WO2020028215A1 (pl)
ZA (2) ZA202100765B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3829551T3 (pl) 2018-07-30 2024-04-02 Biothea Pharma, Inc. Krystaliczna sól malonianu epinefryny
WO2022074127A2 (en) * 2020-10-08 2022-04-14 Catalent U.K. Swindon Zydis Limited Stable oral dispersible formulation for epinephrine and salts or solvates thereof
US12414916B2 (en) 2021-06-10 2025-09-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US11617716B2 (en) 2021-06-10 2023-04-04 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US12661315B2 (en) 2021-06-10 2026-06-23 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
WO2025049636A1 (en) 2023-08-29 2025-03-06 Biothea Pharma, Inc. Polymorphic forms of epinephrine malonate
US20260108465A1 (en) 2024-10-21 2026-04-23 Belhaven BioPharma Inc. Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2332075A (en) 1940-05-24 1943-10-19 Wilson & Co Inc Epinephrine derivative and preparation thereof
US2469967A (en) 1946-04-17 1949-05-10 Armour & Co Cyclopentano perhydrophenanthrene compounds
US2602818A (en) * 1949-07-25 1952-07-08 Parke Davis & Co Process for the purification of epinephrine
IL141762A0 (en) * 1998-10-01 2002-03-10 Novartis Ag New oral formulations
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
TW200800142A (en) 2005-09-09 2008-01-01 Univ Manitoba Fast-disintegrating epinephrine tablets for buccal or sublingual administration
FR2891459B1 (fr) 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
WO2009004593A2 (en) * 2007-07-03 2009-01-08 Wockhardt Research Centre Processes for the preparation of epinephrine
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
US10039710B2 (en) 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
IL300437B1 (en) * 2016-01-07 2026-06-01 Viramal Ltd Gel formulations for transdermal drug delivery to maximize drug concentrations in the stratum corneum and serum and methods of using them
PL3829551T3 (pl) 2018-07-30 2024-04-02 Biothea Pharma, Inc. Krystaliczna sól malonianu epinefryny

Also Published As

Publication number Publication date
KR20210057022A (ko) 2021-05-20
RS65138B1 (sr) 2024-02-29
SMT202400056T1 (it) 2024-03-13
JP2021532161A (ja) 2021-11-25
CA3123928A1 (en) 2020-02-06
US10995059B2 (en) 2021-05-04
US20200031758A1 (en) 2020-01-30
TWI819045B (zh) 2023-10-21
ES2973347T3 (es) 2024-06-19
US20250051262A1 (en) 2025-02-13
EP3829551C0 (en) 2024-01-03
EP3829551A4 (en) 2022-04-20
WO2020028215A1 (en) 2020-02-06
ZA202201224B (en) 2023-11-29
IL280448B2 (en) 2024-12-01
TW202010491A (zh) 2020-03-16
AU2019313324B2 (en) 2024-10-24
US11505521B2 (en) 2022-11-22
ZA202100765B (en) 2022-08-31
AU2019313324A1 (en) 2021-02-04
CN112739334B (zh) 2025-01-28
JP7561118B2 (ja) 2024-10-03
IL280448A (en) 2021-03-25
CN112739334A (zh) 2021-04-30
MX2021001249A (es) 2021-05-27
IL280448B1 (en) 2024-08-01
SG11202100749UA (en) 2021-02-25
US20230086578A1 (en) 2023-03-23
EP3829551B1 (en) 2024-01-03
EP3829551A1 (en) 2021-06-09
US20210214301A1 (en) 2021-07-15
US12134588B2 (en) 2024-11-05
CA3123928C (en) 2023-11-14
KR102847418B1 (ko) 2025-08-18
BR112021001525A2 (pt) 2021-04-20
HRP20240162T1 (hr) 2024-04-12
HUE065984T2 (hu) 2024-07-28

Similar Documents

Publication Publication Date Title
IL273730A (en) crystalline forms
IL276644A (en) crystalline forms
ZA202100765B (en) Crystalline epinephrine malonate salt
IL257306B (en) A compressed pyrimidine compound or a salt thereof
IL290692A (en) Salt
EP3150599A4 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
PL3909584T3 (pl) Związek pirymidynowy lub jego sól
GB201614939D0 (en) Crystalline hydrate
IL265445A (en) crystalline forms
FI3686191T3 (fi) Kiteinen sulfamidiyhdiste
PT3630729T (pt) Composto de pirimidina
EP3250291A4 (en) Crystalline c21h22c12n4o2 malonate
GB201809458D0 (en) Salt form
GB201809460D0 (en) Salt form
GB201818028D0 (en) Crystalline materials
GB201816445D0 (en) Crystalline materials
IL276108A (en) Crystalline forms of psoorstam
SG11202104073XA (en) Malonate salt of varlitinib
GB201904190D0 (en) Salt
HK40058863A (en) Malonate salt of varlitinib
GB201911797D0 (en) Crystalline forms
HK40003395A (en) Crystalline salt forms
ZA201902553B (en) Crystalline forms
HK40044019A (en) Fasoracetam crystalline forms
GB201715010D0 (en) Crystalline forms